Abstract
We tested the hypothesis that plasma brain natriuretic peptide (BNP) levels are elevated in patients with acute cerebrovascular diseases (CVD) independent of heart disease, and reflect CVD severity. After careful evaluations for heart disease, the study included 79 consecutive patients with CVD without any evidence of heart disease admitted within 48 h after onset (71±10 years), and 26 control subjects without CVD (CT, 67±12 years). Ischemic stroke subtypes were defined by the TOAST classification. Large-artery atherosclerosis (LAA, n=27), small-artery occlusion (SAO, n=27), and intracerebral hemorrhage (ICH, n=25) were included. The plasma BNP levels were measured at admission and 1 month later. Stroke severity and brain infarct volume were evaluated. There were no significant differences in the clinical profiles including echocardiographic parameters among the groups. The plasma BNP level (pg/mL) upon admission was higher in LAA (70.6±53.9) than in SAO (38.2±28.4) and CT (28.5±19.9) (both p<0.05). The level in ICH (47.3±28.6) was not significantly different from that in CT. The BNP level in ischemic stroke was positively correlated with the NIH Stroke Scale (NIHSS) (ρ=0.42, p<0.05) and infarct volume (r=0.34, p<0.05). Brain infarct volume and NIHSS were independent contributors to the plasma BNP level in ischemic stroke. One month later, the BNP level was significantly decreased and was similar in all CVD groups. The plasma BNP level transiently increased in patients with LAA independently of heart disease, and reflected infarct volume and the severity of acute ischemic stroke.
Similar content being viewed by others
Article PDF
References
Mukoyama M, Nakao K, Hosoda K, et al: Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87: 1402–1412.
Yasue H, Yoshimura M, Sumida H, et al: Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195–203.
Nakagawa O, Ogawa Y, Itoh H, et al: Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an “emergency” cardiac hormone against ventricular overload. J Clin Invest 1995; 96: 1280–1287.
Sudoh T, Kangawa K, Minamino N, Matsuo H : A new natriuretic peptide in porcine brain. Nature 1988; 332: 78–81.
Saper CB, Hurley KM, Moga MM, et al: Brain natriuretic peptides: differential localization of a new family of neuropeptides. Neurosci Lett 1989; 96: 29–34.
Brosnan MJ, Clark JS, Jeffs B, et al: Genes encoding atrial and brain natriuretic peptides as candidates for sensitivity to brain ischemia in stroke-prone hypertensive rats. Hypertension 1999; 33: 290–297.
Etgen T, Baum H, Sander K, Sander D : Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis. Stroke 2005; 36: 270–275.
Nakagawa K, Yamaguchi T, Seida M, et al: Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke. Cerebrovasc Dis 2005; 19: 157–164.
Sharma JC, Ananda K, Ross I, Hill R, Vassallo M : N-terminal proBrain natriuretic peptide levels predict short-term poststroke survival. J Stroke Cerebrovasc Dis 2006; 15: 121–127.
Iltumur K, Karabulut A, Apak I, Aluclu U, Ariturk Z, Toprak N : Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke. Am Heart J 2006; 151: 1115–1122.
Mukoyama M, Nakao K, Obata K, et al: Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochem Biophys Res Commun 1991; 180: 431–436.
Nishikimi T, Yoshihara F, Morimoto A, et al: Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996; 28: 22–30.
Sutton TM, Stewart RA, Gerber IL, et al: Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 2003; 41: 2280–2287.
Silvet H, Young-Xu Y, Walleigh D, Ravid S : Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 2003; 92: 1124–1127.
Diamond JA, Phillips RA : Hypertensive heart disease. Hypertens Res 2005; 28: 191–202.
Adams HP Bendixen BH Jr Kappelle LJ et al: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35–41.
Brott T, Adams HP Jr, Olinger CP, et al: Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20: 864–870.
Sahn DJ, DeMaria A, Kisslo J, Weyman A : Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–1083.
Teichholz LE, Kreulen T, Herman MV, Gorlin R : Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976; 37: 7–11.
Devereux RB, Reichek N : Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613–618.
Goetze JP, Gore A, Moller CH, Steinbruchel DA, Rehfeld JF, Nielsen LB : Acute myocardial hypoxia increases BNP gene expression. FASEB J 2004; 18: 1928–1930.
Sabatine MS, Morrow DA, de Lemos JA, et al: Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 2004; 44: 1988–1995.
Jiang C, Lu H, Vincent KA, et al: Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1 alpha. Physiol Genomics 2002; 8: 23–32.
Fukui S, Katoh H, Tsuzuki N, et al: Focal brain edema and natriuretic peptides in patients with subarachnoid hemor-rhage. J Clin Neurosci 2004; 11: 507–511.
Modrego PJ, Boned B, Berlanga JJ, Serrano M : Plasmatic B-Type natriuretic peptide and C-reactive protein in hyperacute stroke as markers of CT-evidence of brain edema. Int J Med Sci 2008; 5: 18–23.
Persson L, Hardemark HG, Gustafsson J, et al: S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke 1987; 18: 911–918.
Missler U, Wiesmann M, Friedrich C, Kaps M : S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997; 28: 1956–1960.
Maisel AS, Krishnaswamy P, Nowak RM, et al: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161–167.
Omland T, Aakvaag A, Bonarjee VV, et al: Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996; 93: 1963–1969.
Hachinski VC, Smith KE, Silver MD, Gibson CJ, Ciriello J : Acute myocardial and plasma catecholamine changes in experimental stroke. Stroke 1986; 17: 387–390.
Ay H, Arsava EM, Saribas O : Creatine kinase-MB elevation after stroke is not cardiac in origin: comparison with troponin T levels. Stroke 2002; 33: 286–289.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tomita, H., Metoki, N., Saitoh, G. et al. Elevated Plasma Brain Natriuretic Peptide Levels Independent of Heart Disease in Acute Ischemic Stroke: Correlation with Stroke Severity. Hypertens Res 31, 1695–1702 (2008). https://doi.org/10.1291/hypres.31.1695
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.1695
Keywords
This article is cited by
-
NT-proBNP, cerebral small vessel disease and cardiac function in patients with a recent lacunar infarct
Journal of Human Hypertension (2023)
-
Neuroprotective effect of Crocus sativus against cerebral ischemia in rats
Metabolic Brain Disease (2020)
-
Modulating effects of preconditioning exercise in the expression of ET-1 and BNP via HIF-1α in ischemically injured brain
Metabolic Brain Disease (2019)
-
A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective study
BMC Neurology (2012)
-
Elevated BNP is Associated with Vasospasm-Independent Cerebral Infarction Following Aneurysmal Subarachnoid Hemorrhage
Neurocritical Care (2011)